Pàgina inicial > Articles > Resultats de la cerca: Agents

Articles

  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Articles 145 registres trobats  anterior11 - 20següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
11.
12 p, 1.0 MB Frequency of anticancer drug use at the end of life : a scoping review / Szigethy, Endre (Epidy Kft (Ungria)) ; Dorantes, Rosario (Parc de Salut MAR de Barcelona) ; Sugrañes, Miguel (Universitat Autònoma de Barcelona) ; Madera, Meisser (University of Cartagena. Research Department, Faculty of Dentistry) ; Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau) ; Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Anticancer drug use at the end of life places potential extra burdens on patients and the healthcare system. Previous articles show variability in methods and outcomes; thus, their results are not directly comparable. [...]
2023 - 10.1007/s12094-023-03234-1
Clinical & Translational Oncology, june 2023, p. 1-12  
Registre complet - Creative Commons
12.
9 p, 280.6 KB Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder : A Prospective Study on the Effects of Time / Ferrer Vinardel, Marc (Hospital Universitari Vall d'Hebron) ; Soto-Angona, Óscar (Hospital Universitari Vall d'Hebron) ; Soler Artigas, María (Hospital Universitari Vall d'Hebron) ; Ibáñez, Pol (Hospital Universitari Vall d'Hebron) ; Fadeuilhe, Christian (Hospital Universitari Vall d'Hebron) ; Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ; Lidai, Raquefet (Hospital Universitari Vall d'Hebron) ; Vargas-Cáceres, Sebastian (Hospital Universitari Vall d'Hebron) ; Torrecilla, María Ángeles (Hospital Universitari Vall d'Hebron) ; López Illamola, Anna (Hospital Universitari Vall d'Hebron) ; Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Agitation in patients diagnosed with personality disorders (PD) is one of the most frequent crises in emergency departments (ED). Although many medications have been tested, their effectiveness has been small or non-significant, and no specific drugs are supported by the available evidence. [...]
2022 - 10.9758/cpn.2022.20.3.482
Clinical Psychopharmacology and Neuroscience, Vol. 20 (august 2022) , p. 482-490  
Registre complet - Creative Commons
13.
27 p, 1.0 MB Preventive activities in women. PAPPS update 2022 Actividades preventivas en la mujer. Actualización PAPPS 2022 / López García-Franco, Alberto (Medicina Familiar y Comunitaria. Centro de Salud Dr. Mendiguchía Carriche) ; Baeyens Fernández, José Antonio (Medicina Familiar y Comunitaria. Centro de Salud Universitario de Armilla) ; Iglesias Piñeiro, M. José (Medicina Familiar y Comunitaria. Centro de Salud Vicente Soldevilla) ; Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Ruiz Cabello, Cristina (Medicina Familiar y Comunitaria. Consultorio Castilléjar) ; Pereira Iglesias, Ana (Medicina Familiar y Comunitaria. Centro de Salud Dr. Mendiguchía Carriche) ; Landa Goñi, Jacinta (Medicina Familiar y Comunitaria. Centro de Salud Emisora (Pozuelo de Alarcón))
In the 2022 PAPPS update we present those specific preventive activities for women's health, except those related to cancer prevention (which are included in another document) and those aspects related to differential gender morbidity, a cross-cutting aspect for all working groups. [...]
2022 - 10.1016/j.aprim.2022.102471
Atencion Primaria, Vol. 54 (octubre 2022) , p. 102471  
Registre complet - Creative Commons
14.
17 p, 534.5 KB COAST : An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination with Oleclumab or Monalizumab in Patients with Unresectable, Stage III Non-Small-Cell Lung Cancer / Herbst, Roy S. (Yale Cancer Center. Smilow Cancer Hospital) ; Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ; Barlesi, Fabrice (Gustave Roussy) ; Carcereny, Enric (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Chu, Quincy (Cross Cancer Institute) ; Monnet, Isabelle (Centre Hospitalier Intercommunal de Créteil) ; Sánchez Hernández, Alfredo (Consorci Hospitalari Provincial de Castelló) ; Dakhil, Shaker (Cancer Center of Kansas) ; Camidge, D (University of Colorado Anschutz Medical Campus) ; Winzer, Leanne (AstraZeneca) ; Soo-Hoo, Yee (AstraZeneca) ; Cooper, Zachary A. (AstraZeneca) ; Kumar, Rakesh (AstraZeneca) ; Bothos, John (AstraZeneca) ; Aggarwal, Charu (Abramson Cancer Center. University of Pennsylvania) ; Martinez-Marti, Alex (Vall d'Hebron Institut d'Oncologia)
PURPOSEDurvalumab significantly improves overall survival for patients with unresectable stage III non-small-cell lung cancer and no progression after concurrent chemoradiotherapy (cCRT). Building upon that standard of care, COAST is a phase II study of durvalumab alone or combined with the anti-CD73 monoclonal antibody oleclumab or anti-NKG2A monoclonal antibody monalizumab as consolidation therapy in this setting. [...]
2022 - 10.1200/JCO.22.00227
Journal of Clinical Oncology, Vol. 3 (january 2022) , p. JCO.22.00227  
Registre complet - Creative Commons
15.
18 p, 6.6 MB IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation / Ezeonwumelu, I.J (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; García Vidal, Edurne (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Felip, Eudald (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Puertas, Maria C. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Oriol-Tordera, Bruna (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Gutiérrez-Chamorro, Lucía (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Gohr, André (Max Planck Institute of Molecular Cell Biology and Genetics) ; Ruiz Riol, Marta (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Massanella, Marta (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Badia, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Riveira-Muñoz, Eva (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Ballana, Ester (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Universitat Autònoma de Barcelona
The persistence of latent HIV reservoirs allows for viral rebound upon antiretroviral therapy interruption, hindering effective HIV-1 cure. Emerging evidence suggests that modulation of innate immune stimulation could impact viral latency and contribute to the clearing of HIV reservoir. [...]
2022 - 10.3389/fimmu.2022.1001068
Frontiers in immunology, Vol. 13 (september 2022)  
Registre complet - Creative Commons
16.
33 p, 2.0 MB Diagnosis and management of AML in adults : 2022 recommendations from an international expert panel on behalf of the ELN / Döhner, Hartmut (Ulm University Hospital. Department of Internal Medicine III) ; Wei, Andrew H. (Peter MacCallum Cancer Centre. Royal Melbourne Hospital and University of Melbourne. Department of Haematology) ; Appelbaum, Frederick (University of Washington. Fred Hutchinson Cancer Research Center) ; Craddock, Charles (Centre for Clinical Haematology. Queen Elizabeth Hospital. University of Birminham) ; DiNardo, Courtney D. (The University of Texas MD Anderson Cancer Center. Department of Leukemia) ; Dombret, Hervé (Saint-Louis Institute for Research. Université de Paris. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris. Department of Hematology) ; Ebert, Benjamin L. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Fenaux, P. (Service d'Hématologie Séniors. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris) ; Godley, Lucy A. (The University of Chicago. Section of Hematology/Oncology. Department of Medicine) ; Hasserjian, Robert P (Massachusetts General Hospital) ; Larson, Richard A (University of Chicago. Department of Medicine and Comprehensive Cancer Center) ; Levine, Ross L. (Memorial Sloan Kettering Cancer Center. Human Oncology and Pathogenesis Program and Leukemia Service. Department of Medicine) ; Miyazaki, Yasushi (Atomic Bomb Disease Institute. Nagasaki University. Department of Hematology) ; Niederwieser, Dietger (University of Leipzig) ; Ossenkoppele, Gert (Department of Haematology. Amsterdam UMC. Location VU University Medical Center) ; Röllig, Christoph (Department of Internal Medicine I. University Hospital Carl Gustav Carus TU Dresden) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Stein, Eytan M. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ; Tallman, Martin S. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ; Tien, Hwei-Fang F. (Division of Hematology. Department of Internal Medicine. National Taiwan University Hospital) ; Wang, Jianxiang (Institute of Hematology and Blood Diseases Hospital. Chinese Academy of Medical Sciences & Peking Union Medical College) ; Wierzbowska, Agnieszka (Department of Hematology. Medical University of Lodz) ; Löwenberg, Bob (Department of Hematology. Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute)
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators. [...]
2022 - 10.1182/blood.2022016867
Blood, Vol. 140 Núm. 12 (september 2022) , p. 1345-1377  
Registre complet - Creative Commons
17.
7 p, 321.7 KB Use of fluorescence imaging during lymphatic surgery : A Delphi survey of experts worldwide / Dip, Fernando (Hospital de Clínicas José de San Martín) ; Alexandru, Nistor (Universitatea de Medicina si Farmacie Victor Babes) ; Amore, Miguel (Central Military Hospital) ; Becker, Corinne (AP-HP Hôpital Européen Georges Pompidou) ; Belgrado, Jean-Paul (University of Brussels) ; Bourgeois, Pierre (University of Brussels) ; Chang, Edward I-Fei (MD Anderson Cancer Center) ; Koshima, Isao (Tottori University) ; Liberale, Gabriel (University of Brussels) ; Masià, Jaume (Institut d'Investigació Biomèdica Sant Pau) ; Mortimer, Peter (St. Georges University Hospital) ; Neligan, Peter (University of Washington) ; Batista, Bernardo Noriega (AC Camargo Cancer Center) ; Olszewski, Waldemar (Polish Academy of Sciences) ; Salvia, Sophia Alexia (Central Military Hospital) ; Suami, Hiroo (Australian Lymphedema Education. Research and Treatment (ALERT). Faculty of Medicine. Health and Human Sciences. Macquarie University) ; Vankerckhove, Sophie (University of Brussels) ; Yamamoto, Takumi (National Center for Global Health and Medicine) ; Lo Menzo, Emanuele (Cleveland Clinic Florida) ; White, Kevin P. (ScienceRight Research Consulting Services) ; Rosenthal, Raul J. (Cleveland Clinic Florida) ; Universitat Autònoma de Barcelona
Background: Fluorescence imaging with indocyanine green is increasingly used during lymphedema patient management. However, to date, no guidelines exist on when it should and should not be used or how it should be performed. [...]
2022 - 10.1016/j.surg.2022.08.026
Surgery (United States), Vol. 172 Núm. 6 (december 2022) , p. S14-S20  
Registre complet - Creative Commons
18.
16 p, 1.1 MB Synthesis, antiviral evaluation, and computational studies of cyclobutane and cyclobutene L-nucleoside analogues / Miralles Llumà, Rosa (Universitat Autònoma de Barcelona. Departament de Química) ; Figueras, Antoni (Universitat Autònoma de Barcelona. Departament de Química) ; Busqué Sánchez, Félix (Universitat Autònoma de Barcelona. Departament de Química) ; Alvarez-Larena, Angel (Universitat Autònoma de Barcelona. Servei de Difracció de Raigs X) ; Balzarini, Jan (KU Leuven. Rega Institute for Medical Research) ; Figueredo Galimany, Marta (Universitat Autònoma de Barcelona. Departament de Química) ; Font i Cierco, Josep (Universitat Autònoma de Barcelona. Departament de Química) ; Alibes, Ramón (Universitat Autònoma de Barcelona. Departament de Química) ; Maréchal, Jean-Didier (Universitat Autònoma de Barcelona. Departament de Química)
This paper describes the stereoselective synthesis of a series of functionalized cyclobutane and cyclobutene L-nucleoside analogues featuring a methylene spacer between the carbocycle and the nucleobase. [...]
2013 - 10.1002/ejoc.201301097
European journal of organic chemistry, Vol. 2013, issue 34 (Dec. 2013) , p. 7761-7775  
Registre complet -
19.
33 p, 1004.1 KB Synthesis of novel nucleoside analogues built on a bicyclo[4.1.0]heptane scaffold / Domínguez Pérez, Beatriz (Universitat Autònoma de Barcelona. Departament de Química) ; Ferrer Mallofré, Èric (Universitat Autònoma de Barcelona. Departament de Química) ; Figueredo Galimany, Marta (Universitat Autònoma de Barcelona. Departament de Química) ; Maréchal, Jean-Didier (Universitat Autònoma de Barcelona. Departament de Química) ; Balzarini, Jan (KU Leuven. Rega Institute for Medical Research) ; Alibes, Ramón (Universitat Autònoma de Barcelona. Departament de Química) ; Busqué Sánchez, Félix (Universitat Autònoma de Barcelona. Departament de Química)
A new class of carbocyclic nucleoside analogues built on a bicyclo[4. 1. 0]heptane scaffold, a perspective novel pseudosugar pattern, have been conceived as anti-HSV agents on the basis of initial protein-ligand docking studies. [...]
2015 - 10.1021/acs.joc.5b01413
Journal of organic chemistry, Vol. 80, issue 19 (Oct. 2015) , p. 9495-9505  
Registre complet -
20.
21 p, 1.1 MB Novel Antithrombotic Agents in Ischemic Cardiovascular Disease : Progress in the Search for the Optimal Treatment / Barriuso, I. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Worner, F. (Hospital Universitario Arnau de Vilanova. Institut de Recerca Biomèdica de Lleida) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Ischemic cardiovascular diseases have a high incidence and high mortality worldwide. Therapeutic advances in the last decades have reduced cardiovascular mortality, with antithrombotic therapy being the cornerstone of medical treatment. [...]
2022 - 10.3390/jcdd9110397
Journal of Cardiovascular Development and Disease, Vol. 9 Núm. 11 (november 2022) , p. 397  
Registre complet - Creative Commons

Articles : 145 registres trobats   anterior11 - 20següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem